Abstract:Background A high model of end-stage liver disease (MELD) score (>30) adversely affects outcomes even if patients receive prompt liver transplantation (LT). Therefore, balanced allocation of donor grafts is indispensable to avoid random combinations of donor and recipient risk factors, which often lead to graft or recipient loss. Predictive models aimed at avoiding donor risk factors in high-MELD score recipients are urgently required to obtain satisfactory outcomes. Method Data of patients with MELD score >30 who underwent LT at three transplantation institutes between 2015 and 2018 were retrospectively reviewed. Early allograft dysfunction (EAD), length of intensive care unit (ICU) stay, and graft loss were recorded. Corresponding independent risk factors were analyzed using stepwise multivariable regression analysis. A prediction model of graft loss was developed, and discrimination and calibration were measured. Results After applying the exclusion criteria, 778 patients were enrolled. The incidence of EAD was 34.8% (271/778). Donor graft macrovesicular steatosis, graft-to-recipient weight ratio (GRWR), warm ischemia time (WIT), cold ischemia time (CIT), and ABO blood incompatibility, together with donor serum albumins, were independent predictors of EAD. The incidence of ICU stay over 10 days was 64.7% (503/778). Donor age, recipient's MELD score, Child score, and CIT were independent predictors of ICU stay. The 3-year graft survival rates (GSRs) in the training and validation cohorts were 64.2 and 59.3%, respectively. The independent predictors of graft loss were recipient's Child score, ABO blood type incompatibility, donor serum total bilirubin over 17.1 μmol/L, and cold CIT. A nomogram based on these variables was internally and externally validated and showed good performance (area under the receiver operating characteristic curve = 70.8 and 66.0%, respectively). For a recipient with a high MELD score, the avoidance of ABO blood type incompatibility and CIT ≥6 h would achieve a 3-year GSR of up to 78.4%, whereas the presence of the aforementioned risk factors would decrease the GSR to 35.4%. Conclusion The long-term prognosis of recipients with MELD scores >30 could be greatly improved by avoiding ABO blood type incompatibility and CIT ≥6 h.

Does Model for End-Stage Liver Disease Score Predict the Short-Term Outcome of Living Donor Liver Transplantation?

Prediction Value of Model for End-Stage Liver Disease Scoring System on Prognosis in the Acute on Chronic Liver Failure Patients with Plasma Exchange Treatment.

Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35

Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation

Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients

Posttransplant Mortality Risk Assessment for Adult-to-adult Right-Lobe Living Donor Liver Recipients with Benign End-Stage Liver Disease

Survival after live donor versus deceased donor liver transplantation: propensity score-matched study

Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system

Therapeutic Evaluation of the Patients with High MELD Scores Undergoing Liver Transplantation for Benign End-Stage Liver Disease

Liver Transplantation in Acute-on-chronic Liver Failure Patients with High Model for End-Stage Liver Disease (MELD) Scores: a Single Center Experience of 100 Consecutive Cases.

A brief model evaluated outcomes after liver transplantation based on the matching of donor graft and recipient

Emergent Right Lobe Adult-to-adult Living-Donor Liver Transplantation for High Model for End-Stage Liver Disease Score Severe Hepatitis.

Model for end-stage liver disease score in predicting acute kidney injury and prognosis in patients receiving liver transplantation

Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry

Downgrading Meld Improves the Outcomes after Liver Transplantation in Patients with Acute-On-Chronic Hepatitis B Liver Failure

The contribution of perioperative prognosis evaluation of patients underwent living donor liver transplantation with Acute Physiology and Chronic Health Evaluation Ⅱ models and MELD

Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendations

[Influence of Recipient Pretransplant MELD-AS Score and Graft Size on the Outcome of Adult-to-adult Living Donor Liver Transplantation].

Comparison of the Child-Turcotte-Pugh Classification and the Model for End-stage Liver Disease Score as Predictors of the Severity of the Systemic Inflammatory Response in Patients Undergoing Living-donor Liver Transplantation

New Prognostic Model For Adult-To-Adult Living Donor Liver Transplant Recipients

Value of pediatric end-stage liver disease score in predicting prognosis after pediatric living donor liver transplantation